The pursuit of more effective and targeted cancer therapies is spurring the evolution of antibody-based treatments. At the Antibody-based Cancer Therapies conference, we will explore the potential of emerging antibody formats that are driving the oncology field, including novel antibody scaffolds, multispecifics, complex bioconjugates, and antibody-based cell therapies. Attendees will gain insights into the broadening therapeutic landscape that includes protein degraders, immunocytokines, and nucleic acids, while witnessing the power of combination therapies that are pushing the boundaries of cancer treatment.